What was recalled
This page synthesizes the hydrolyzed fish protein framework in commercial pet food, with particular focus on the multiple distinct framework purposes that the same general ingredient category serves. Hydrolyzed fish protein is produced from whole fish, fish by-products (heads, frames, viscera, skin) and specific fish-meal grades through controlled enzymatic hydrolysis with bacterial or fungal proteases. Source fish vary substantially across the category: cold-water marine species (Atlantic salmon, Atlantic cod, pollock, herring, anchovy, menhaden) and warm-water and freshwater species (tilapia, catfish, pangasius). Each source fish has different amino acid profile, omega-3 fatty acid content, and palatability profile.
The palatability enhancement framework is the most common commercial use. Partially hydrolyzed fish protein delivers high free amino acid content (particularly glutamic acid, the umami-flavor amino acid, plus aspartic acid, glycine, and other palatant amino acids) plus small peptide concentration that pets find highly attractive. The hydrolysate is typically applied as a surface coating on extruded kibble after the main extrusion process, since extrusion itself would denature the palatability-active peptides. Brands using fish-derived palatants include both fish-anchored formulations (where the surface coating reinforces the primary protein source) and non-fish-anchored formulations (where the fish-derived palatant enhances overall acceptance of poultry or beef-anchored kibble). Brand-level disclosure of palatant source is uneven; many formulations using fish-derived palatant do not disclose the inclusion explicitly.
The hypoallergenic protein source framework is the less common but clinically more consequential use. Extensively hydrolyzed fish protein with peptide molecular weight predominantly under 3 kDa serves as hypoallergenic protein source in some therapeutic formulations, parallel to extensively hydrolyzed whey protein. The framework requires controlled hydrolysis intensity to reduce peptide size below the immunological allergen-recognition threshold (approximately 10 kDa), clinical validation in food-allergic patient populations, and brand-level peptide molecular weight specification. Therapeutic prescription hypoallergenic diets occasionally use fish protein hydrolysate as alternative to whey hydrolysate (particularly for pets with confirmed milk-protein allergy); over-the-counter "hydrolyzed fish" formulations may use partial hydrolysis without functional allergen reduction.
Why it was recalled
The structural concerns have three layers. Layer one — hydrolysis intensity determines framework purpose, but is rarely disclosed: the same general ingredient category ("hydrolyzed fish protein") covers substantially different processing intensities serving substantially different framework purposes. Brand-level disclosure of hydrolysis intensity (partial, moderate, extensive) and peptide molecular weight specification is uncommon outside therapeutic prescription hypoallergenic diet contexts. Pet owners cannot easily distinguish a palatant-purpose hydrolysate from a hypoallergenic-purpose hydrolysate through ingredient labeling alone.
Layer two — palatability enhancement is not therapeutic claim: partially hydrolyzed fish protein used as palatability enhancer serves a legitimate and well-established formulation function. The concern is when brand marketing conflates palatant-purpose hydrolyzed fish inclusion with hypoallergenic-purpose hydrolyzed fish inclusion, producing consumer expectation that may not align with product function. For pets with confirmed food allergy, palatant-purpose hydrolyzed fish (at typical 5-50 kDa peptide molecular weight) may retain substantial allergenic potential and may even produce IgE-mediated reaction in fish-allergic pets, parallel to the framework concerns covered on our whey protein hydrolysate page.
Layer three — fish source disclosure varies substantially: "hydrolyzed fish protein" as ingredient label may reference single-species source (Atlantic salmon hydrolysate, Atlantic cod hydrolysate) or mixed-source hydrolysate (pooled fish meal from multiple species and source fisheries). For pets with documented fish-species sensitivity, single-species source identification is critical; mixed-source hydrolysate cannot be reliably evaluated for cross-reactivity. Brand-level transparency around fish source disclosure is uneven outside therapeutic prescription diet contexts.
Health risks for your pet
Hydrolyzed fish protein at typical pet food inclusion rates is generally well-tolerated and safe for dogs and cats. The primary safety concerns are: fish allergen reactivity in fish-allergic pets — partial hydrolysis may not adequately reduce allergenic potential below IgE-recognition threshold, and pets with confirmed fish allergy should avoid hydrolyzed fish inclusion unless the formulation is documented extensively hydrolyzed therapeutic product; histamine and scombrotoxin formation in poor-quality fish sources or improperly processed hydrolysate, particularly for tuna and mackerel family fish with high histidine content; heavy metal bioaccumulation in long-lived predator fish (tuna, swordfish, shark) that occasionally surface in pet food fish sources, though most pet food fish ingredients come from shorter-lived species with lower bioaccumulation; cross-reactivity with other seafood proteins in pets with documented seafood sensitivity; and ethoxyquin or BHA antioxidant residues in some imported fish meal products with non-EU-aligned antioxidant practices.
The pet-food-specific concern is the consumer-disclosure gap around hydrolysis purpose and intensity. Brands using hydrolyzed fish protein as palatability enhancer should be evaluated on overall formulation transparency and palatability framework; brands marketing hydrolyzed fish inclusion as hypoallergenic protein source warrant scrutiny around hydrolysis intensity, peptide molecular weight specification, and clinical validation evidence. The framework parallels the whey hydrolysate consumer-disclosure framework.
What to do if you bought affected product
Pet owners can interpret hydrolyzed fish protein pet food inclusion appropriately through several practical approaches: (1) distinguish palatability-enhancement purpose from hypoallergenic protein source purpose — the same ingredient category serves substantially different framework purposes through substantially different processing intensities; brand-level disclosure of hydrolysis intensity (partial, moderate, extensive) and peptide molecular weight specification is the underlying transparency framework; (2) for pets with confirmed food allergy, work with your veterinarian to identify clinically validated therapeutic hypoallergenic options — over-the-counter "hydrolyzed fish" formulations may use partial hydrolysis without functional allergen reduction; therapeutic prescription hypoallergenic diets with documented extensively hydrolyzed protein are the appropriate framework for confirmed food allergy management; (3) request fish source disclosure — for pets with documented fish-species sensitivity, single-species source identification is critical; mixed-source hydrolysate cannot be reliably evaluated for cross-reactivity; (4) watch for histamine and scombrotoxin reactions — pets with sudden gastrointestinal symptoms, urticaria, or facial swelling shortly after consuming fish-anchored pet food warrant veterinary evaluation for histamine reaction; (5) consider broader formulation transparency — brands disclosing fish source, hydrolysis purpose and intensity, peptide molecular weight specification, and any clinical validation typically reflect better overall formulation transparency than brands using generic "hydrolyzed fish protein" labeling; (6) recognize that palatability enhancement is legitimate function — brand marketing of palatant-purpose hydrolyzed fish inclusion is not inherently problematic; the concern is when palatability-purpose inclusion is conflated with hypoallergenic-purpose inclusion in marketing language.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not currently differentiate hydrolyzed fish protein framework at the brand level per our published methodology, since hydrolysis intensity and framework purpose vary substantially and brand-level transparency is uneven. Future rubric extension under consideration: brands with explicit hydrolysis purpose disclosure (palatability vs hypoallergenic protein), peptide molecular weight specification, fish source disclosure (single-species vs mixed), and clinical validation evidence for hypoallergenic claims would warrant favorable scoring weight as transparency signal; brands using generic "hydrolyzed fish protein" or "hydrolyzed salmon" marketing without underlying disclosure would warrant scoring caution particularly when conflated with hypoallergenic positioning. The related hypoallergenic protein framework is covered on our whey protein hydrolysate page. For now, our recommendation: distinguish palatability-enhancement purpose from hypoallergenic-protein-source purpose, work with veterinarian for confirmed food allergy management, and prioritize brand-level fish source and hydrolysis transparency.